Skip to main contentSkip to navigation
Sirius Investors
NervGen Pharma Corp.

NervGen Pharma Corp.

NGENF
OTCHealthcare

NGENF Earnings Reports, EPS & Revenue History

Quarterly EPS and revenue vs. estimates for NervGen Pharma Corp.. Review beat/miss history, upcoming consensus figures, and earnings call transcripts when available.

EPS and Earnings Announcement

Latest Quarterly EPS
Next Earnings Announcement
Unlock for free

Already registered? Sign in

EPS vs. Estimates

Green band = beat vs estimate · Red band = miss · Lines show actual and consensus EPS.

EPS & Revenue vs. Estimates

Upgrade
DateEPS ActualEPS Est.EPS Diff.
Nov 24, 2025
-0.04-0.06+0.02
Aug 28, 2025
-0.09-0.06-0.04
May 14, 2025
-0.04-0.06+0.02
Nov 14, 2024
Aug 22, 2024
May 16, 2024
Nov 14, 2022
Aug 10, 2022
May 12, 2022
Feb 28, 2022
Nov 18, 2021

Earnings Call Transcripts

Upgrade

Earnings Call Transcripts Require Subscription

Access to earnings call transcripts and AI-powered summaries is available for Pro, Premium, and Enterprise subscribers.

View Pricing Plans

Revenue Breakdown

Want to understand NGENF's revenue sources? Explore detailed revenue breakdowns by product line and geographic region to see what's driving the company's top line.

View Revenue Breakdown